Sign In
Buy ATHX
$0.0135
+0 (+0%)
At Close: Apr 05, 2024
Exclusive: U.S. companies got emergency government loans despite having months of cash
05:44pm, Thursday, 07'th May 2020
When American companies recently applied for U.S. government loans meant to help small businesses survive the coronavirus crisis, they had to certify they needed the cash to cover basic needs like sal
5 Stem Cell Companies Racing Towards COVID-19 ARDS Therapy
04:35pm, Thursday, 07'th May 2020
Athersys and Mesoblast enroll first patients in Phase II/III placebo controlled COVID-19 ARDS trials. Capricor, Mesoblast and Pluristem make waves with very pro
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Analyst Believes Potential COVID-19 Treatment Can Push Ahersys (ATHX) Stock up to $12
06:32pm, Wednesday, 06'th May 2020
Many small biotech players have put the foot on the gas in 2020. With the urgent need for a COVID-19 vaccine and treatment still the number one global priority, this comes as no surprise.Athersys (ATH
Akari Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
02:47pm, Tuesday, 05'th May 2020
Akari announced positive top line Phase 2 data. Athersys progresses with multistem COVID-19 therapy. SCWorx announces cancellation of COVID-19 test kit order.
The first patients have been enrolled in the Athersys COVID-19 induced ARDS clinical program using MultiStem cell therapy.
The first patients have been enrolled in the Athersys COVID-19 induced ARDS clinical program using MultiStem cell therapy.
Here's Why Athersys Tumbled 23.3% in April
03:19pm, Monday, 04'th May 2020
Shares of Athersys (NASDAQ: ATHX) declined more than 23% last month, according to data provided by S&P; Global Market Intelligence. The stem cell stock's April decline was really just a matter of tim
Winfield Associates, Inc. Buys Invesco Taxable Municipal Bond, iShares –-' Year Treasury ...
12:00am, Monday, 04'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
12:00am, Saturday, 02'nd May 2020
Melbourne-based biotech company Mesoblast will enroll up to 300 COVID-19 patients for a randomized, controlled study of its stem cell therapy.
Athersys Reports University Hospitals Cleveland Medical Center Now Open As Clinical Site For MACOVIA Coronavirus Trial
10:16am, Friday, 01'st May 2020
The first clinical site is now open for the MACOVIA study, a pivotal Phase 2/3 study evaluating MultiStem® cell therapy for COVID-19 induced ARDS
